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A BST R AC T   
 
Aim: Fournier's gangrene (FG) is a rare, rapidly progressing and life-threatening disease of the genital, perianal 
and perineal regions. We aimed to evaluate etiological parameters, accompanying diseases, current treatment 
methods and factors affecting mortality in patients with FG. 
Method: The medical records of 38 patients who were operated by the same team with a diagnosis of FG from 
December 2015 to January 2021 were retrospectively reviewed. Those patients were divided into two groups: 
survivors (Group 1), and non-survivors (Group 2). Comparisons were made regarding clinical and 
demographic features; comorbid diseases; leukocyte count at first presentation; etiological factors; treatment 
outcomes; and mortality rates. 
Results: Thirty-eight patients (24 males, 14 females) were evaluated; mean age was 60.2 ± 13.2 years. While 
76.3% (n = 29) of these patients recovered with treatment, the total mortality rate was 23.7% (n = 9). The most 
common cause of the FG and comorbidity were anorectal diseases (n = 22; 57.9%) and type 2 diabetes mellitus 
(n = 21; 55.3%), respectively. Female gender, septic shock, necrosis, abdominal wall and lumbar region 
involvement, chronic renal failure, FG development secondary to postoperative complications and ostomy 
rates were higher in non-survivors. There were no significant differences between the two groups regarding 
leukocyte count at first presentation, number of debridement, dressing methods, reconstruction methods, and 
length of hospital stay. 
Conclusions: Female gender, presence of septic shock and necrosis on physical examination, involvement of 
the abdominal wall and lumbar region in addition to the perianal region, chronic renal failure, disease 
secondary to postoperative complications and the necessity of ostomy play an important role in mortality. 
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Introduction 
In 1883, Dr Jean Alfred Fournier described an 
infection with unknown origin that led to rapid 
necrosis of the scrotal skin in young healthy 
men [1]. This infection is now called Fournier’s 
gangrene (FG), although other definitions have 
been proposed, such as necrotising fasciitis, as 
suggested by Wilson in 1952 [2]. The term FG 
is now more widely implemented to genital, 
perianal, perirectal and abdominal wall 
infections. Although the initial definition does 
not contain a known etiology, trauma and 
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infection of the perianal and genital areas seem 
to play an important role in this disease [3]. FG 
can occur after colorectal and urinary system 
pathologies, perineal infections, perianal or 
genital trauma and any surgical intervention in 
the above-mentioned areas. This disease, which 
appears suddenly and progresses rapidly, is 
mostly mortal if not it is under control with 
early treatment [4, 5]. It can affect both genders 
and individuals in all ages [6].  
Predisposing factors include diabetes mellitus, 
hypertension, coronary and peripheral artery 
diseases, obesity, smoking, drug addiction, 
poor hygiene, chronic alcoholism, 
malignancies and immunosuppression [7, 8]. 
This disease, which is difficult to diagnose 
without necrosis or gangrene, can show a rapid 
course and lead to death [9]. Early diagnosis of 
FG and determining the correct treatment 
method are very important for survival. The 
emergency treatment of FG begins with 
surgical debridement and broad-spectrum 
antibiotic therapy [3]. After the initial 
comprehensive debridement, a series of 
repetitive debridement may be required. An 
effective dressing is very valuable in treatment. 
In recent years, negative pressure wound 
therapy (NPWT) has gained popularity and is 
widely used in wound management [10].  
Despite the advancement of knowledge on 
etiology, diagnosis, treatment and intensive 
care techniques, the mortality rate of FG 
patients is still high. The incidence of FG is 
increasing especially in developed countries 
aging population. Therefore, it is important to 
understand the predisposing factors, 
pathophysiology and clinical course of this 
disease. In this study, we aimed to review our 
experiences of FG treatment and to evaluate the 
etiological parameters, accompanying diseases, 
current treatment methods and factors affecting 
mortality in patients with FG. 
Materials and methods 
Ethical approval was obtained from the Local 
Ethics Committee for this study (IRB approval 
number OMU: 2020/751). The medical records 
of 38 patients who were operated by the same 
team with a diagnosis of FG from December 
2015 to January 2021 were retrospectively 
reviewed. The diagnosis of FG was established 
based on patient history, clinical symptoms, 
physical examination at presentation and 
radiological findings.  
The patients were divided into two groups as 
follows: survivors (Group 1, n = 29) and non-
survivors (Group 2, n = 9). Demographic 
characteristics of the patients, initial symptoms, 
involved areas, etiological factors, 
comorbidities, leukocyte count at first 
presentation, number of debridement, dressing 
methods (wet or negative aspiration system), 
the presence of a diverting ostomy, 
reconstruction methods, and length of hospital 
stay were recorded and compared between the 
two groups. The effect of these parameters on 
clinical results was investigated.  
All data were analyzed by using SPSS 
(Statistical Package for Social Sciences) for 
Windows 15.0 program. In the comparison of 
qualitative data, descriptive statistical methods 
(mean or median and standard deviation) and 
Pearson's chi-square test were used. The Mann-
Whitney U test and independent samples t-test 
were used for binary comparisons of 
continuous variables. A value of p< 0.05 was 
accepted as statistically significant. 
 
Results  
Thirty-eight patients who were operated by the 
same team for FG were included in this study. 
While 29 (76.3%) of these patients recovered 
with treatment, 9 (23.7%) patients were 
deceased. Data on patient age, gender, clinical 
features, leukocyte count at first presentation  
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   Table 1. Patient demographics, clinical features, leukocyte count at first presentation and comorbid diseases 







Age* (years) 59.5 (12.9) 62.5 (14.6) 60.2 (13.2) .559 
Gender      
     Female 8 (27.6%) 6 (66.7%) 14 (36.8%) 
.034 
     Male 21 (72.4%) 3 (33.3%) 24 (63.2%) 
Initial symptoms     
     Perianal swelling 22 (75.9%) 2 (22.2%) 24 (63.2%) .040 
     Perianal pain 20 (69%) 1 (11.1%) 21 (55.3%) .002 
     Necrosis 9 (31%) 8 (88.9%) 17 (44.7%) .002 
     Fever 11 (37.9%) 1 (11.1%) 12 (31.6%) .130 
     Perineal pain 9 (31%) 1 (11.1%) 10 (26.3%) .236 
     Crepitus 7 (24.1%) 3 (33.3%) 10 (26.3%) .584 
     Septic shock 1 (3.4%) 6 (66.7%) 7 (18.4%) <.001 
     Scrotal swelling 5 (17.2%) 2 (22.2%) 7 (18.4%) .736 
     Vulvar swelling 3 (10.3%) 2 (22.2%) 5 (13.2%) .689 
Involved area     
     Perianal 24 (82.8%) 4 (44.4%) 28 (73.7%) .023 
     Genital 14 (48.3%) 4 (44.4%) 18 (47.4%) .841 
     Perineal 14 (48.3%) 3 (33.3%) 17 (44.7%) .431 
     Abdominal wall 4 (13.8%) 7 (77.8%) 11 (28.9%) <.001 
     Lumbar region 4 (13.8%) 4 (44.4%) 8 (21.1%) .049 
Etiology     
     Anorectal 19 (65.5%) 3 (33.3%) 22 (57.9%) .088 
     Urogenital 3 (10.3%) 3 (33.3%) 6 (15.8%) .098 
     Cutaneous 4 (13.8%) 0 4 (10.5%) .239 
     Postoperative complication 1 (3.4%) 3 (33.3%) 4 (10.5%) .011 
     Trauma 2 (6.9%) 0 2 (5.3%) .418 
     COVID-19  1 (3.4%) 0 1 (2.6%) .572 
Leukocyte count at first 
presentation* (u/L) 17047 (7336) 16735 (8206) 16973 (7436) .914 
Comorbid disease     
     Diabetes 17 (58.6%) 4 (44.4%) 21 (55.3%) .455 
     Hypertension 7 (24.1%) 4 (44.4%) 11 (28.9%) .241 
     Coronary artery disease 7 (24.1%) 2 (22.2%) 9 (23.7%) .906 
     Malignancy 5 (17.2%) 3 (33.3%) 8 (21.1%) .301 
     Chronic renal failure 2 (6.9%) 3 (33.3%) 5 (13.2%) .040 
     Cerebrovascular disease 3 (10.3%) 2 (22.2%) 5 (13.2%) .357 
    *Data is presented as mean (standard deviation), Bold values indicate statistical significance. 
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Table 2. The etiology of Fournier’s gangrene. 
Etiology Group I Group II Total 
Anorectal 19 (50%) 3 (7.9%) 22 (57.9%) 
     Perianal abscess 10 (26.5%) 1 (2.6%) 11 (29.1%) 
     Fistula to the rectum 1 (2.6%) - 1 (2.6%) 
     Ischiorectal abscess 4 (10.5%) - 4 (10.5%) 
     Perforated appendicitis 1 (2.6%) - 1 (2.6%) 
     Rectum cancer 1 (2.6%) - 1 (2.6%) 
     Perforated cecum tumor - 1 (2.6%) 1 (2.6%) 
     Rectum perforation / foreign body 1 (2.6%) - 1 (2.6%) 
     Diverticular perforation 1 (2.6%) 1 (2.6%) 2 (5.3%) 
Urogenital 3 (7.9%) 3 (7.9%) 6 (15.8%) 
     Scrotal abscess 1 (2.6%) 1 (2.6%) 2 (5.3%) 
     Vulvar abscess 1 (2.6%) 2 (5.3%) 3 (7.9%) 
     Bartholin abscess 1 (2.6%) - 1 (2.6%) 
Cutaneous 4 (10.5%) 0 4 (10.5%) 
     Decubitus ulcer 2 (5.3%) - 2 (5.3%) 
     Perineal soft tissue infection 2 (5.3%) - 2 (5.3%) 
Postoperative complication 1 (2.6%) 3 (7.9%) 4 (10.5%) 
     Haemorrhoidal disease 1 (2.6%) - 1 (2.6%) 
     Intestinal anastomotic leak - 2 (5.3%) 2 (5.3%)  
     Colostomy complication - 1 (2.6%) 1 (2.6%) 
Trauma 2 (5.3%) 0 2 (5.3%) 
COVID-19  1 (2.6%) 0 1 (2.6%) 
 
Table 3. Treatment outcomes for Fournier’s gangrene. 
Parameters Group I (n=29) Group II (n=9) Total (n=38) P value 
Number of debridement* 3 (2-20) 3 (2-12) 3 (2-20) .927 
Dressing methods     
     Wet-dressing 
     NPWT 
4 (13.8%) 0   
.266 25 (86.2%) 9 (100%) 34 (89.5%) 
Ostomy 8 (27.6%) 6 (66.7%) 14 (36.8%) .034 
Reconstruction     
     Fasciocutaneous flap 
     Split-thickness skin graft 
4 (13.8%) 2 (22.2%) 6 (15.8%) 
.203 8 (27.6%) 0 8 (21.1%) 
Length of hospital stay (day) 23 (3-59) 20 (4-86) 22 (3-86) .447 
 
NPWT: negative pressure wound therapy, *Data is presented as median (min-max value), Bold value 
indicate statistical significance. 
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and comorbid diseases are presented in Table 1.  
The mean age was 60.2 ± 13.2 years and 63.2% 
of the population was male. Female gender was 
significantly higher in Group 2 (p<0.05).  
When the initial symptoms were compared, 
perianal swelling and perianal pain were 
significantly higher in Group 1, and septic 
shock and necrosis in Group 2 (p<0.05). 
Perianal involvement was more common in 
Group 1 and abdominal wall and lumbar region 
involvement in Group 2 (p<0.05).  
Etiological origins are shown in Table 1 and 
Table 2, and the most common cause of 
Fournier's gangrene was a perianal or perirectal 
infection spreading to the perineum, 
external urogenital organs, abdominal wall, and 
lumbar region. FG developing secondary to 
postoperative complications was significantly 
higher in Group 2 (p<0.05). There was no 
statistical difference between the groups in 
terms of leukocyte count at first presentation. 
The most common comorbid disease was 
diabetes mellitus (21 patients; 55.3%). 33% of 
the patients who died from Fournier's gangrene 
had chronic renal failure. In Group 1, Fournier's 
gangrene occurred in 1 patient during COVID 
19 treatment and in 2 patients after blunt 
perineal trauma due to falling from height 
(Table 2).  
There were no significant differences between 
the two groups regarding number of 
debridement, dressing methods, reconstruction 
methods, and length of hospital stay (p>0.05). 
Ostomy was required in 8 (27.6%) patients in 
Group 1 and 6 (66.7%) patients in Group 2 due 
to anal sphincter defect or surgical wound 
contamination. Stoma rate was higher in Group 
2 (p<0.05) (Table 3). 
 
Discussion 
Fournier's gangrene (FG) is a rare but serious 
and progressive infection that can affect the 
genital area, perineum and lower abdominal 
wall separately or together [3]. As the causative 
microorganisms multiply, the infection spreads 
to the anatomical fascial planes. The 
pathognomonic histological findings on FG are 
necrosis of the superficial and deep fascial 
planes, fibrin deposition within and around the 
arterioles [11]. FG predominantly occurs in 
individuals aged between 30 and 60 [12]. In a 
recent study, although this disease is detected at 
all ages, it has been reported mostly in 
individuals in their fifties [13]. This aggressive 
disease process is associated with a high 
mortality rate of 20-30% [14]. There are 
different results in the literature regarding age 
as a prognostic factor for death. Sorensen et al. 
[15] emphasized that the prognosis worsens 
with increasing patient age, while Yeniyol et al. 
[16] found no statistical difference in age 
between survivors and non-survivors. The 
mean age of the patients in the present study 
was 60.2 years and the mortality rate was 
23.7%. We did not observe any significant 
difference in age among groups. While FG has 
been known to be a predominantly male disease 
since scrotal involvement was used as the key 
component of the original FG definition, the 
definition has expanded with the presentation 
of this disease also in women [17]. Although 
FG was observed less frequently in women in 
our study, the mortality rate was found to be 
significantly higher. Similarly, Czymek et al. 
[18] stated that female gender is a prognostic 
factor for mortality. On the other hand, this 
result may be due to the fact that the study was 
conducted with a smaller number of patients. 
Patients usually come to the emergency service 
within a few days after the onset of complaints 
such as purulent rectal discharge, perineal 
edema or pain. Infectious sources are mostly 
anorectal diseases, urological diseases, 
intraperitoneal events or traumatic injuries, and 
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in some cases the cause may not be determined 
[19, 20]. In this study, the main patient 
complaints were perianal swelling, perianal 
pain, and necrosis around the anus. The 
mortality rate was significantly higher in 
patients who had symptoms of necrosis and 
septic shock at presentation, and accompanying 
abdominal wall and lumbar region involvement 
in addition to perianal involvement. Although 
many diseases have been reported to be 
positively associated with FG, especially 
diabetes mellitus is the most important 
predisposing factor among them [3, 21]. On the 
other hand, the relationship between diabetes 
mellitus and mortality is still controversial. 
Some studies report an association with both 
incidence and mortality, while others only show 
a relationship with incidence. In our study, 
55.3% of the patients had diabetes mellitus; 
however, there was no significant association 
between diabetes mellitus and mortality. In a 
recent study, FG with extensive soft tissue 
necrosis and pre-existing chronic kidney 
disease was associated with poor prognosis 
[22]. Similarly, chronic renal failure was 
statistically more common in non-survivors in 
this study.  
Previously, FG was generally known as a 
urological disease, but now it is mainly of 
concern to general surgeons as the most 
common etiology is colorectal-derived 
diseases. Stephens et al. found a higher 
mortality in patients with colorectal-derived FG 
compared to other etiologies [23]. Necrotizing 
soft tissue infections caused by intestinal 
perforation can occur in an atypical fashion 
with significant morbidity and mortality rates 
[24]. When anorectal etiologies and 
postoperative colorectal surgery complications 
were evaluated together, it was seen that they 
constituted 68.4% of the total etiology in our 
study. Moreover, mortality rate was high in FG 
cases developing secondary to postoperative 
colorectal surgery complications. Fournier's 
gangrene was detected in a 76-year-old female 
patient who was followed up in the intensive 
care unit due to respiratory failure secondary to 
COVID-19. COVID-19, which suppresses the 
immune system, has emerged as another 
etiological factor. The above mentioned patient, 
who underwent emergency and aggressive 
debridement along with COVID-19 treatment, 
was discharged on the 7th week of 
hospitalization. It has been reported that a high 
mean leukocyte count at first presentation is a 
prognostic factor for mortality [25]. On the 
contrary, no significant difference was found 
among the groups in terms of leukocyte count 
in our study.  
Early diagnosis, urgent debridement and 
adequate administration of broad-spectrum 
antibiotics are the most essential component of 
treatment [26]. In this study, aggressive 
debridement and broad-spectrum antibiotic 
therapy were performed to all patients. Serial 
debridement was continued until necrotic 
lesions disappeared at the wound site. The 
median amount of debridement for both groups 
was 3 and there was no statistically significant 
difference between the groups. A conventional 
wet-to-dry dressing is a well-known, popular, 
inexpensive and accepted method with many 
advantages such as keeping the wound clean. 
NPWT is a widely used another method of 
wound treatment [27]. Once the necrosis is 
eliminated, NPWT helps the wound heal 
physiologically. The negative pressure leads to 
increased blood flow and the migration of 
inflammatory cells to into the wound site [28]. 
NPWT requires less frequent change compared 
to traditional dressings and is a less painful 
procedure. This also prevents bacterial 
contamination and accelerates the formation of 
granulation tissue with the removal of exudates 
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[29,30]. NPWT treatment was used in 89.5% of 
all patients, and there was no statistically 
significant difference between the groups in 
terms of wound therapy.  
The debridement area usually carries the risk of 
faecal contamination [31]. Therefore, a faecal 
diversion is an important attempt at FG 
treatment. Loop colostomy is often used in 
patients with severe perineal involvement and 
wounds close to the anus [32]. The literature 
has shown that patients requiring ostomy has a 
poor prognosis [15]. 36.8% of the patients 
required ostomy and there was statistically 
significant association between ostomy and 
prognosis. Stoma rate was statistically higher in 
non-survivors. Early closure of tissue defects is 
an important part of treatment. Various 
reconstructive methods are available for good 
functional and cosmetic results. There is no 
consensus on the best method of reconstruction. 
The reconstructive treatment should be based 
on the patient's clinical characteristics, patient 
preference, and surgeon's judgment [33]. We 
preferred either fasciocutaneous flap or split-
thickness skin graft in wounds with large tissue 
defects that did not close with secondary 
healing after NPWT treatment. Major wounds 
caused by debridement in FG patients usually 
take a long time to heal and thus require a long 
hospital stay. Although Ersay et al. [20] have 
determined that longer hospital stay was a 
factor affecting survival, there was no 
statistically significant difference between the 
groups in terms of hospital stay in our study.  
The limitation of this study was associated with 
the disadvantages caused by the retrospective 
design. Although the data were collected in a 
five-year period, the sample size was small. 
Another limitation was that when the patient 
data were analyzed retrospectively, we could 
not reach all the necessary laboratory values to 
calculate the FGSI score. Therefore, we could 
not use this parameter to compare between 
groups. FG with diffuse soft tissue necrosis is 
associated with poor prognosis and complex 
patient management. Rapid recognition of 
disease spread and patient's poor prognostic 
factors is essential to reduce mortality and 
establish a management plan for this disease. In 
spite of development in medical treatment and 




Fournier’s gangrene is a serious surgical 
emergency with a high mortality rate. Female 
gender, presence of septic shock and necrosis 
on physical examination, involvement of the 
abdominal wall and lumbar region in addition 
to the perianal region, chronic renal failure, 
disease secondary to postoperative 
complications and the necessity of ostomy play 
an important role in mortality. 
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